Pictet Asset Management (Switzerland)’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-77,698
Closed -$1.99M 1746
2021
Q4
$1.99M Buy
+77,698
New +$2.42M ﹤0.01% 998

Other funds holding TSVT

Pictet Asset Management (Switzerland)'s TSVT Position: Q1 2022 in Review

Pictet Asset Management (Switzerland) sold out of 2seventy bio (TSVT) in Q1 2022, closing a stake of 77,698 shares — an estimated $1.99M sold.

Pictet Asset Management (Switzerland) first reported a position in TSVT in Q4 2021 and held it in 1 quarter. The position peaked at $1.99M in Q4 2021. 134 funds tracked by Wall St. Rank hold TSVT as of Q1 2022.

  • Pictet Asset Management (Switzerland) reported no remaining 2seventy bio position as of Q1 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 77,698 2seventy bio shares in Q1 2022, an estimated $1.99M.
  • Pictet Asset Management (Switzerland) first reported a position in 2seventy bio in Q4 2021 and held it in 1 quarter.
  • Pictet Asset Management (Switzerland)'s 2seventy bio position peaked at $1.99M in Q4 2021.
  • 134 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 13 May 2022.